Medicare Enrolled

Dr. John Strickler, MD

Internal Medicine · Durham, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
DUMC TRENT DR, Durham, NC 27710
9196848111
In practice since 2006 (19 years)
NPI: 1265523377 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Strickler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Strickler? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Strickler

Dr. John Strickler is an internal medicine specialist in Durham, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Strickler performed 298 Medicare services across 151 unique beneficiaries.

Between the years covered by Open Payments, Dr. Strickler received a total of $269,518 from 36 pharmaceutical and/or device companies across 241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Strickler is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 298 Medicare services $269,518 industry payments

Medicare Practice Summary

Medicare Utilization ↗
298
Medicare services
Bottom 27% in NC for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
151
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
184 $100 $344
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
57 $92 $250
New patient office visit, complex (60-74 min) 35 $125 $490
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $138 $486
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
11 $83 $272
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$269,518
Total received (2018-2024)
Avg $38,503/year across 7 years
Top 1% in NC for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
241
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$241,101 (89.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,527 (5.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,891 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$97,435
2023
$55,751
2022
$34,474
2021
$20,726
2020
$25,485
2019
$8,972
2018
$26,675

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$16,774
Regeneron Pharmaceuticals, Inc.
$15,815
Takeda Pharmaceuticals U.S.A., Inc.
$10,593
Incyte Corporation
$6,442
SANOFI US SERVICES INC.
$5,310
Ipsen Biopharmaceuticals, Inc
$5,267
Merck Sharp & Dohme LLC
$4,857
Amgen Inc.
$3,773
F. Hoffmann-La Roche AG
$3,375
PFIZER INC.
$3,365
GE HEALTHCARE
$2,832
Astellas Pharma Global Development
$2,704
BeiGene USA, Inc.
$2,625
E.R. Squibb & Sons, L.L.C.
$2,580
Bayer Healthcare Pharmaceuticals Inc.
$2,457
Eli Lilly and Company
$2,245
Janssen Scientific Affairs, LLC
$2,025
Daiichi Sankyo Inc.
$1,875
GlaxoSmithKline, LLC.
$1,767
Astellas Pharma Inc
$754
Top 3 companies account for 44.3% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$58,649
Seagen Inc.
$19,998
Takeda Pharmaceuticals U.S.A., Inc.
$18,670
ABBVIE INC.
$16,774
Regeneron Pharmaceuticals, Inc.
$15,815
AbbVie Inc.
$14,898
Merck Sharp & Dohme LLC
$11,797
Seattle Genetics, Inc.
$11,279
F. Hoffmann-La Roche AG
$10,907
Bayer Healthcare Pharmaceuticals Inc.
$7,371
ARRAY BIOPHARMA INC
$7,234
GlaxoSmithKline, LLC.
$7,193
Incyte Corporation
$6,525
Amgen Inc.
$5,448
SANOFI US SERVICES INC.
$5,310
Ipsen Biopharmaceuticals, Inc
$5,267
PFIZER INC.
$4,305
AstraZeneca Pharmaceuticals LP
$4,220
Daiichi Sankyo Inc.
$4,080
Mylan Inc.
$3,920
Genentech USA, Inc.
$3,485
GE HEALTHCARE
$2,832
Astellas Pharma Global Development
$2,704
BeiGene USA, Inc.
$2,625
E.R. Squibb & Sons, L.L.C.
$2,580
Eli Lilly and Company
$2,245
Janssen Scientific Affairs, LLC
$2,025
TAIHO ONCOLOGY, INC.
$1,980
Chugai Pharmaceutical Co., Ltd.
$1,980
Celgene Corporation
$1,927
Janssen Research & Development, LLC
$1,362
AstraZeneca UK Limited
$1,342
Hoffmann-La Roche Limited
$994
Lilly USA, LLC
$800
Astellas Pharma Inc
$754
Genentech, Inc.
$221
Top 3 companies account for 36.1% of all-time payments
Associated products mentioned in payments ›
Abraxane · Avastin · BRAFTOVI · Enhertu · FRUZAQLA · IMFINZI · KEYTRUDA · LIBTAYO · LONSURF · LUMAKRAS · Nexavar · Non-Covered · Non-Covered Product · Onivyde · PEMAZYRE · RYBREVANT · Stivarga · TECENTRIQ · TEVIMBRA · TUKYSA · Vectibix · Vitrakvi · Vyloy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for internal medicine in NC.

Looking for an internal medicine specialist in Durham?
Compare internal medicine physicians in the Durham area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Strickler is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 1% of NC peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Strickler experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Strickler performed 184 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Strickler receive payments from pharmaceutical companies?
Yes. Dr. Strickler received a total of $269,518 from 36 companies across 241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Strickler's costs compare to other internal medicine physicians in Durham?
Dr. Strickler's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Strickler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →